scholarly journals Hepatocellular carcinoma with duodenal invasion resected subsequent to multimodal therapies: A case report

2019 ◽  
Vol 60 ◽  
pp. 348-352
Author(s):  
Takashi Ito ◽  
Tetsuro Hirose ◽  
Atsushi Matsumoto ◽  
Akitada Yogo ◽  
Tomoko Okuno ◽  
...  
1999 ◽  
Vol 49 (3) ◽  
pp. 384-387 ◽  
Author(s):  
Richard Farrell ◽  
Martina Morrin ◽  
David Lewis ◽  
Ram Chuttani ◽  
Douglas Pleskow

2018 ◽  
Vol 2 ◽  
pp. 5
Author(s):  
Scott P Patterson ◽  
Richard G Foster

This case report describes the chemoembolization of a small hepatocellular carcinoma employing a lipiodol drug delivery system utilizing a novel arterial pathway. Because the target lesion was precariously located adjacent to the inferior heart border and the diaphragm, it was unsuitable for imaging-guided microwave ablation. To achieve chemoembolization, several intraprocedural adaptations were necessary, given the variant anatomy encountered and difficulty accessing the left gastric artery through a celiac artery approach. The left gastric artery was selected from a superior mesenteric artery approach through the pancreaticoduodenal arcade (Rio Branco’s arcade). This case illustrates the importance of a mastery of the vascular anatomy and variants of hepatic arterial flow.


2021 ◽  
Vol 16 (3) ◽  
pp. 550-554
Author(s):  
Moheieldin M Abouzied ◽  
Ahmed Fathala ◽  
Ahmad AlMuhaideb ◽  
Hadeel Almanea ◽  
Abdulaziz S Al-Sugair ◽  
...  

2007 ◽  
Vol 11 (1) ◽  
pp. 61-63 ◽  
Author(s):  
A. Atra ◽  
R. Al-Asiri ◽  
S. Wali ◽  
H. Al-Husseini ◽  
A Al-Bassas ◽  
...  

2021 ◽  
Vol 2021 (4) ◽  
Author(s):  
Jacqueline B Baikovitz ◽  
Lindsay Thornton ◽  
Monica T Garcia-Buitrago ◽  
Alan S Livingstone ◽  
Matthew T Studenski ◽  
...  

Abstract Yttrium-90 (Y-90) trans-arterial radioembolization (TARE) is used in the management of unresectable hepatocellular carcinoma (HCC). During the last 5 years, dosimetry software has been developed to allow for a more rigorous approach of dose prescription in Y-90 TARE. We present here a case study of a 77-year-old woman diagnosed with HCC, who underwent a Y-90 TARE as a bridge procedure to liver resection. This clinical scenario represents a unique opportunity to illustrate the predictive value of dosimetric findings correlating dosimetry with pathological findings. In this case, Y-90 TARE dosimetry was predictive of treatment response in which the tumor received a mean dose of 156 Gy and demonstrated a complete pathologic response.


Sign in / Sign up

Export Citation Format

Share Document